Geode Capital Management, LLC Portage Biotech Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.16 - $11.95 $234,336 - $542,697	-45,414 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.57 - $12.0 $2,700 - $4,932	-411 Reduced 0.9%	45,414 $298,000
Q4 2021 Feb 11, 2022	BUY	$10.73 - $23.74 $2,103 - $4,653	196 Added 0.43%	45,825 $491,000
Q3 2021 Nov 12, 2021	BUY	$13.65 - $22.4 $144,553 - $237,215	10,590 Added 30.22%	45,629 $927,000
Q2 2021 Aug 13, 2021	BUY	$20.96 - $42.81 $734,417 - $1.5 Million	35,039 New	35,039 $734,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $69.5M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.